Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

Share Price is delayed by 15 minutes
Get Live Data
4,401.50    117.00 (2.73%)
Bid:
4,382.00
Ask:
4,383.50
Spread: 1.50 (0.034%)
Market Cap: £95.31b
ULVR Live PriceLast checked at - London Stock Exchange

Intraday Unilever Share Chart

Directorate Change

25 Feb 2025 07:00

RNS Number : 2812Y
Unilever PLC
25 February 2025
 

 

Unilever PLC Board Update

 

Fernando Fernandez to succeed Hein Schumacher as Chief Executive Officer

 

Board is committed to further accelerating Growth Action Plan and building Unilever into global industry leader

 

Company reaffirms 2025 outlook and medium-term guidance

 

 

Unilever today announced that Hein Schumacher is stepping down as Chief Executive Officer and as a Board Director on 1 March 2025 by mutual agreement and will leave the company on 31 May 2025.

 

Fernando Fernandez, currently Unilever Chief Financial Officer and Executive Director, will be appointed Chief Executive Officer effective from 1 March 2025. Prior to becoming CFO in January 2024, Fernando had a successful tenure as President of Beauty & Wellbeing, one of Unilever's fastest growing businesses. In previous roles as President Latin America, CEO Brazil and CEO Philippines he led some of the company's best performing markets, delivering strong financial results while developing exceptional talent.

 

Unilever Chairman Ian Meakins said: "On behalf of the Board, I would like to thank Hein for resetting Unilever's strategy, for the focus and discipline he has brought to the company and for the solid financial progress delivered during 2024. Hein introduced and led a significant productivity programme and the commencement of the Ice Cream separation, both of which are fully on track. The Growth Action Plan (GAP) has put Unilever on a path to higher performance and the Board is committed to accelerating its execution. We are grateful for Hein's leadership, and we wish him the very best for the future."

 

Speaking of Fernando's appointment as CEO, Ian Meakins said: "The Board has been impressed with Fernando's decisive and results-oriented approach and his ability to drive change at speed. He partnered in the development of the GAP and in driving the productivity programme. He has a strong track record of performance and portfolio management, a love of brands and a profound knowledge of Unilever's operations.

 

"While the Board is pleased with Unilever's performance in 2024, there is much further to go to deliver best-in-class results. Having worked with Fernando closely over the last 14 months, the Board is very confident in his ability to lead a high performing management team, realise the benefits of the GAP with urgency, and deliver the shareholder value that the company's potential demands."

 

Hein Schumacher said: "It has been a privilege to lead Unilever. We have made real progress and I am proud of what we have achieved in a short period of time. With a clear strategy, a portfolio reset in motion and a strong leadership team in place, I look forward to seeing Unilever move from strength to strength in the future."

 

Fernando Fernandez said: "Being appointed as CEO of Unilever is an honour. Our focus will be on building a future-fit portfolio with an attractive growth footprint and delivering unmatched functional and perceivable superiority across our top 30 power brands. I have full confidence in our team's ability to propel Unilever to a global industry-leading position and create substantial value for our shareholders. I would like to thank Hein for his values-led leadership and the performance focus he has brought to the business. I wish him every success for the future."

 

A thorough internal and external search process is being initiated to appoint a permanent CFO. From 1 March 2025, Srinivas Phatak, currently Unilever's Deputy Chief Financial Officer and Group Controller, will become acting CFO. Srinivas has served in global and local senior finance, strategy and supply chain roles including a successful term as CFO of Hindustan Unilever Limited. Srinivas' leadership qualities and his broad experience will enable him to partner Fernando in successfully executing Unilever's strategy.

 

There is no change to Unilever's 2025 outlook or the company's medium-term guidance.

 

This announcement contains inside information. This is a public announcement pursuant to Article 17 Paragraph 1 of the European Market Abuse Regulation (596/2014), including as it forms part of UK law.

 

Summary of remuneration in respect of Directorate changes

New CEO

Fernando will receive Fixed Pay of Euro 1,800,000 and be eligible to participate in an annual bonus and Performance Share Plan awards, all in line with Unilever's existing remuneration policy.

Full details will be set out in the Remuneration Report.

Departing CEO

Hein will continue to receive his current level of Fixed Pay (Euro 1,850,000) up to the cessation of his employment on 31 May 2025. He will then be eligible for a payment in lieu of the remainder of his notice period. 

Hein will be treated as a good leaver under the Remuneration Policy for the purposes of his outstanding incentives. 

Additional details for Hein will be set out in the Section 430(2B) disclosure that will be made available on the Company's website following his departure from the Board, and will also be set out in the Remuneration Report.

 

ENDS

Enquiries

 

Media:

Unilever Press Office

press-office.london@unilever.com

 

Investors:

Investor Relations Team investor.relations@unilever.com

 

About Unilever

We are a global consumer goods business with a portfolio of Beauty & Wellbeing, Personal Care, Home Care, Foods and Ice Cream brands. Our products are used by 3.4 billion consumers every day from household necessities to premium indulgences. We have around 120,000 employees and generated €60.8bn turnover in 2024.

For more information about Unilever and our brands, please visit www.unilever.com.

 

Safe Harbour

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995, including with relation to Unilever's share buyback, its purpose and timetable. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Words and terminology such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', 'ambition', 'target', 'goal', 'plan', 'potential', 'work towards', 'may', 'milestone', 'objectives', 'outlook', 'probably', 'project', 'risk', 'seek', 'continue', 'projected', 'estimate', 'achieve' or the negative of these terms and other similar expressions of future performance, results, actions or events, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current beliefs, expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the 'Group'). They are not historical facts, nor are they guarantees of future performance or outcomes. All forward-looking statements contained in this announcement are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements.

Because these forward-looking statements involve known and unknown risks and uncertainties, a number of which may be beyond the Group's control, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These forward-looking statements are based upon current beliefs, expectations and assumptions regarding anticipated developments and other factors affecting the Group. They are not historical facts, nor are they guarantees of future performance or outcomes. All forward-looking statements contained in this announcement are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements.

The forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any intention, obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. New risks and uncertainties arise over time, and it is not possible for us to predict those events or how they may affect us. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2023 and the Unilever Annual Report and Accounts 2023 available on our corporate website www.unilever.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATIMBTMTMTTLA
Date   Source Headline
10th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20266:17 pmRNSCompletion of 2026 Share Buyback
3rd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20265:13 pmRNSTotal Voting Rights
1st Jun 202610:37 amRNSDirector/PDMR Shareholding
1st Jun 202610:29 amRNSTotal Voting Rights
27th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
18th May 20264:35 pmRNSDirector/PDMR Shareholding
15th May 20265:45 pmRNSPublication of Information Memorandum
15th May 20265:07 pmRNSPublication of UFN Financial Statements
13th May 20263:54 pmRNSResult of AGM
13th May 20267:00 amRNSTransaction in Own Shares
6th May 20265:49 pmRNSDirector/PDMR Shareholding
6th May 20267:00 amRNSDirector/PDMR Shareholding
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20263:08 pmRNSTotal Voting Rights
30th Apr 20267:01 amRNSShare Buy-Back Programme
30th Apr 20267:00 amRNSQ1 2026 Trading Statement
20th Apr 20261:58 pmRNSDirector/PDMR Shareholding
1st Apr 20264:42 pmRNSTotal Voting Rights
31st Mar 20263:00 pmRNSNotice of AGM
31st Mar 20261:00 pmRNSUnilever Foods and McCormick Agreement
31st Mar 20267:00 amRNSResponse to Media Speculation
20th Mar 20267:00 amRNSResponse to media speculation
6th Mar 20264:21 pmRNSDirector/PDMR Shareholding
6th Mar 20264:09 pmRNSPortfolio Update
2nd Mar 20265:50 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSGroup Company Secretary Change
19th Feb 20267:00 amRNSDirector/PDMR Shareholding
16th Feb 20264:38 pmRNSDirector/PDMR Shareholding
16th Feb 20264:26 pmRNSDirector/PDMR Shareholding
13th Feb 20264:57 pmRNSDirector Declaration
12th Feb 20265:11 pmRNSPublication of Supplement
12th Feb 20267:00 amRNS2025 Full Year Results
5th Feb 20264:06 pmRNSNotification of issuance of equity securities
2nd Feb 20264:14 pmRNSTotal Voting Rights
8th Jan 202610:17 amRNSTotal Voting Rights
2nd Jan 20265:21 pmRNSTotal Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSCancellation of Treasury Shares
10th Dec 202511:29 amRNSDirector/PDMR Shareholding
8th Dec 20255:51 pmRNSUpdate on Share Consolidation
8th Dec 20257:00 amRNSCompletion of demerger of Ice Cream Business
5th Dec 20257:00 amRNSDemerger of Unilever’s Ice Cream Business
3rd Dec 20252:50 pmRNSCancellation of Treasury Shares
1st Dec 20256:22 pmRNSTotal Voting Rights
19th Nov 202512:23 pmRNSDirector/PDMR Shareholding
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
4th Nov 20256:21 pmRNSUpdate on Demerger & Share Consolidation Timetable

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.